NeuBase Therapeutics, Inc.

NeuBase Therapeutics, Inc.verified

NBSE

Price:

$0.378

Market Cap:

$1.42M

Operating as a pre-clinical biopharmaceutical company, NeuBase Therapeutics, Inc. is dedicated to pioneering therapeutic solutions for rare genetic disorders and various cancers stemming from aberrant genes. At the core of its approach is the proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform. This technology is being utilized to target ailments such as Huntington's disease (HD) and myotonic dystrophy, in addition to a broader spectrum of genetic conditions and applications within oncology. The company's leading therapeutic candidates encompass NT0100, a PATrOL-powered anti-gene therapy for Huntington's disease; NT0200, another PATrOL-enabled anti-gene solution for my...[Read more]

Industry

Biotechnology

IPO Date

2004-05-28

Stock Exchange

NASDAQ

Ticker

NBSE

The Dividend Yield as of June 2026 (TTM) for NeuBase Therapeutics, Inc. (NBSE) is 0%

According to NeuBase Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

NeuBase Therapeutics, Inc. (NBSE) Historical Dividend Yield (quarterly & annually)

How has NBSE Dividend Yield performed in the past?

The mean historical Dividend Yield of NeuBase Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), NBSE's Dividend Yield was at its highest in in the December 2013 quarter at 0%. The Dividend Yield was at its lowest in in the December 2013 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

NeuBase Therapeutics, Inc. (NBSE) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of NeuBase Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20220%0%
20210%0%
20200%0%
20190%0%
20180%0%
20170%0%
20160%0%
20150%0%
20140%0%
20130%0%

NeuBase Therapeutics, Inc. (NBSE) Average Dividend Yield

How has NBSE Dividend Yield performed in the past?

The current Dividend Yield of NeuBase Therapeutics, Inc. (NBSE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

NeuBase Therapeutics, Inc. (NBSE) Dividend Yield vs. Peers

How is NBSE’s Dividend Yield compared to its peers?

NeuBase Therapeutics, Inc.’s Dividend Yield is less than Oncternal Therapeutics, Inc. (0%), less than OncoSec Medical Incorporated (0%), less than Cassava Sciences, Inc. Warrant (0%), less than ASLAN Pharmaceuticals Limited (0%), less than VBI Vaccines Inc. (0%), less than CohBar, Inc. (0%), less than Timber Pharmaceuticals, Inc. (0%), less than 9 Meters Biopharma, Inc. (0%), less than Impel Pharmaceuticals Inc. (0%), less than Altamira Therapeutics Ltd. (0%),

Build a custom stock screener for NeuBase Therapeutics, Inc. (NBSE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuBase Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeuBase Therapeutics, Inc. (NBSE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeuBase Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is NeuBase Therapeutics, Inc.'s Dividend Yield?

How is the Dividend Yield calculated for NeuBase Therapeutics, Inc. (NBSE)?

What is the highest Dividend Yield for NeuBase Therapeutics, Inc. (NBSE)?

What is the 3-year average Dividend Yield for NeuBase Therapeutics, Inc. (NBSE)?

What is the 5-year average Dividend Yield for NeuBase Therapeutics, Inc. (NBSE)?

How does the current Dividend Yield for NeuBase Therapeutics, Inc. (NBSE) compare to its historical average?